U.S. market Closed. Opens in 1 day 3 hours 30 minutes

DYN | Dyne Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
RevenueN/AN/AN/AN/AN/AN/A506.00M1.37B842.00M1.47B3.00M3.00M1.58B2.32B2.47B3.55B3.10B
Cost of Revenue2.46M3.35M1.09M700.00K271.00K24.00K2.93B2.28B2.03B1.15B1.15B268.00M963.00M1.18B1.19B1.85B2.01B
Gross Profit-2.46M-3.35M-1.09M-700.00K-271.00K-24.00K-2.43B-915.00M-1.19B321.00M-1.14B-265.00M622.00M1.14B1.27B1.70B1.09B
Operating Expenses242.16M170.96M150.03M58.65M13.83M4.79M189.00M161.00M128.00M-308.00M97.00M-81.00M135.00M163.00M-519.00M-494.00M-203.00M
Selling, General & Admin31.40M28.20M28.72M13.45M2.79M517.00K189.00M161.00M128.00M-97.00M97.00M-22.00M135.00M163.00M-159.00M-157.00M-203.00M
Research & Development210.76M142.76M121.31M45.20M11.04M4.28MN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Other Operating ExpensesN/A2.86M-8.00K-790.00K-1.32M-21.00KN/AN/AN/A-211.00MN/A-59.00MN/AN/A-360.00M-337.00MN/A
Operating Income-242.16M-170.96M-150.03M-58.65M-13.83M-4.79M-412.00M-640.00M64.00M-318.00M-318.00M714.00M-236.00M-11.00M-834.00M709.00M605.00M
Other Expenses / Income6.22M2.86M734.00K-790.00K-1.03M-16.00K-126.00M-649.00M-491.00M50.00M-99.00M-627.00M-2.04B-224.00M-521.00M-463.00M-338.00M
Before Tax Income-235.94M-168.10M-149.29M-59.44M-14.86M-4.81M-538.00M-1.29B-427.00M-268.00M-417.00M87.00M-2.28B-235.00M-1.35B246.00M267.00M
Income Tax ExpensesN/A-2.86M-8.00K-700.00K-1.32M-11.00K-610.00M-45.00M-474.00M117.00M-58.00M-627.00M-632.00M197.00M315.00M-75.00M-151.00M
Net Income-235.94M-165.24M-149.28M-58.74M-13.54M-4.81M76.00M-1.24B50.00M-67.00M-356.00M87.00M-1.65B-234.00M-1.26B174.00M264.00M
Interest ExpensesN/A2.92MN/A396.00KN/A5.00K616.00M625.00M546.00M67.00M97.00MN/A357.00M363.00M415.00M427.00M384.00M
Basic Shares Outstanding59.68M51.98M50.90M14.40M45.42M10.32M162.00M129.00M125.00M126.00M100.00M100.00M122.00M120.00M1.01B870.00M1.76B
Diluted Shares Outstanding59.68M51.98M50.90M14.40M45.42M10.32M162.00M129.00M126.00M126.00M100.00M100.00M122.00M121.00M1.01B870.00M1.76B
EBITDA-233.48M-164.75M-148.20M-58.34M-14.59M-4.79M949.00M106.00M736.00M292.00M150.00M113.00M-1.57B734.00M-173.00M902.00M830.00M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%187.55%7.76%87.41%19.92%5,000.00%3,766.67%-99.31%31.60%-7.01%25.42%26.75%
EBIT-235.94M-165.18M-149.29M-59.04M-14.86M-4.82M82.00M-660.00M122.00M117.00M-317.00M-540.00M-1.92B326.00M-532.00M526.00M497.00M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%16.21%-48.32%14.49%7.98%-10,566.67%-18,000.00%-121.14%14.03%-21.56%14.82%16.02%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙